Invention Grant
- Patent Title: Anti-fibrotic agent
-
Application No.: US17031183Application Date: 2020-09-24
-
Publication No.: US11666560B2Publication Date: 2023-06-06
- Inventor: Mikell Paige , Gregory Petruncio , Yun Michael Shim
- Applicant: George Mason University
- Applicant Address: US VA Fairfax
- Assignee: George Mason University
- Current Assignee: George Mason University
- Current Assignee Address: US VA Fairfax
- Agency: Dave Law Group LLC
- Agent Raj S. Dave
- Main IPC: C07D225/00
- IPC: C07D225/00 ; A61K31/436 ; A61K31/439 ; A61P11/00
Abstract:
Tacrolimus is an immunosuppressant drug. The present disclosure provides an anti-fibrotic agent by transforming Tacrolimus, such that the anti-fibrotic agent is used for treating fibrosis. The anti-fibrotic agent is not immunosuppressant. In one embodiment, the present invention provides a method to transform Tacrolimus into an anti-fibrotic agent.
Public/Granted literature
- US20220087986A1 ANTI-FIBROTIC AGENT Public/Granted day:2022-03-24
Information query
